Your Health, We Care
The TIVO-3 trial is a phase 3 clinical trial for patients with recurrent or refractory metastatic renal cell carcinoma. Patients treated with Tivozanib are more than five times more likely to experience long-term progression free survival than those treated with sorafenib.
Tivozanib, as a novel targeted anti-cancer drug, has shown positive prospects in the treatment of advanced renal cell carcinoma.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
